Literature DB >> 29508028

[Controlled cyclophotocoagulation (COCO) : What needs to be considered?]

P-R Preußner1.   

Abstract

The major disadvantage of modern laser cyclocoagulation is the low predictability of therapeutic success in individual cases. Unwanted damage and complications of controlled cyclophotocoagulation (COCO) are very unlikely, particularly because of the high selectivity of photoabsorption. Therefore, these interventions can and must be repeated if the intraocular pressure reduction is insufficient after the initial treatment or if the pressure increases again later. The indications and protocol for repeat interventions are the same as for the initial intervention.

Keywords:  Ciliary body; Pressure reduction; Real time control; Reproducibility; Risk profile

Mesh:

Year:  2018        PMID: 29508028     DOI: 10.1007/s00347-018-0677-1

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  32 in total

1.  Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for primary open-angle glaucoma.

Authors:  P R Egbert; S Fiadoyor; D L Budenz; P Dadzie; S Byrd
Journal:  Arch Ophthalmol       Date:  2001-03

2.  [Controlled cyclophotocoagulation].

Authors:  P R Preussner
Journal:  Ophthalmologe       Date:  1998-09       Impact factor: 1.059

3.  Neodymium laser cyclocoagulation.

Authors:  H Beckman; H S Sugar
Journal:  Arch Ophthalmol       Date:  1973-07

4.  Ocular hazards of transscleral laser radiation. II. Intraocular injury produced by ruby and neodymium lasers.

Authors:  R S Smith; M N Stein
Journal:  Am J Ophthalmol       Date:  1969-01       Impact factor: 5.258

5.  Steps to optimize transscleral photocoagulation.

Authors:  P R Preussner; O Schwenn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-05       Impact factor: 3.117

6.  Sympathetic ophthalmia following laser cyclocoagulation.

Authors:  N E Bechrakis; N W Müller-Stolzenburg; H Helbig; M H Foerster
Journal:  Arch Ophthalmol       Date:  1994-01

7.  Long-term outcome of initial ciliary ablation with contact diode laser transscleral cyclophotocoagulation for severe glaucoma. The Diode Laser Ciliary Ablation Study Group.

Authors:  O Kosoko; D E Gaasterland; I P Pollack; C L Enger
Journal:  Ophthalmology       Date:  1996-08       Impact factor: 12.079

8.  Evaluation of a protocol for transscleral neodymium: YAG cyclophotocoagulation in one hundred patients.

Authors:  C Hampton; M B Shields; K N Miller; M Blasini
Journal:  Ophthalmology       Date:  1990-07       Impact factor: 12.079

Review 9.  [Treatment of refractory glaucoma by diode semiconductor laser cyclophotocoagulation].

Authors:  P Hamard; J Kopel; F Valtot; S Quesnot; H Hamard; J Haut
Journal:  J Fr Ophtalmol       Date:  1995       Impact factor: 0.818

10.  Contact transscleral cyclophotocoagulation with diode laser in refractory glaucoma.

Authors:  R Brancato; R G Carassa; P Bettin; M Fiori; G Trabucchi
Journal:  Eur J Ophthalmol       Date:  1995 Jan-Mar       Impact factor: 1.922

View more
  1 in total

1.  Two-year efficacy after first transscleral controlled cyclophotocoagulation in patients with and without pseudoexfoliation.

Authors:  Markus Lenzhofer; Melchior Hohensinn; Wolfgang Hitzl; Veit Steiner; Armin Motaabbed; Karolina Motloch; Hans Peter Colvin; Herbert A Reitsamer; Sarah Moussa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-04-02       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.